HC relief to Abbott India, allows Rs 48 crore spent on gifts to doctors in 2008-09 to be claimed as expense

Published On 2023-02-16 13:51 GMT   |   Update On 2023-02-16 13:51 GMT

Mumbai: In respite to drug maker Abbott India Ltd., the Bombay High Court has ruled that the CBDT Circular issued in 2012 as per which the expenses incurred in granting freebies to doctors is inadmissible under Section 37 of the Income Tax Act, 1961, since it is prohibited by law, would not be applicable to the assessment year 2008-09.A writ petition was filed by Abbott India (As successor...

Login or Register to read the full article

Mumbai: In respite to drug maker Abbott India Ltd., the Bombay High Court has ruled that the CBDT Circular issued in 2012 as per which the expenses incurred in granting freebies to doctors is inadmissible under Section 37 of the Income Tax Act, 1961, since it is prohibited by law, would not be applicable to the assessment year 2008-09.

A writ petition was filed by Abbott India (As successor of Solvay Pharma India Ltd.), challenging the notice issued by the Assistant Commissioner of Income Tax (ACIT) on 27 March 2015 under Section 148 of the Income Tax Act, 1961 for the purpose of reopening of the assessment for the assessment year 2008-09.

Abbott also challenged the Order dated 16 December 2015 passed by ACIT rejecting objections fled by the company challenging the validity of the re-assessment proceedings.

In its Income Tax Return filed for the assessment year 2008-2009, Abbott India, claimed Rs.48,34,49,690/- as expenditure on gifts as a part of sales promotion expenses. Besides this, the firm claimed an amount of Rs.2,24,14,000/- as expenditure on account of distribution of samples of medicines manufactured by the pharma company and debited under the category ‘physician sample’. Both these expenses were claimed as deduction in computing the total income of the petitioner.

The said expenses were allowed in the assessment order passed by the Assessing Officer (AO).

Later, the petitioner’s case was selected for scrutiny assessment. A notice was issued in 2015 under Section 148 of the Income Tax Act was issued on the petitioner, seeking to re-assess its income for the assessment year 2008-09, on the ground that the AO had reason to believe that petitioner’s income for the relevant assessment year had escaped assessment, within the meaning of Section 147 of the Income Tax Act.

The revenue department furnished the basis for re-opening of the assessment that, "The Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002 on 10 December 2009 imposed a prohibition on the medical practitioner and their professional associations form taking any Gifts, Travel facility, Hospitality, Cash or monetary grant from the pharmaceutical and allied health sector industries."

Further, the Central Board of Direct Taxes (CBDT) had issued a Circular No.5/2012 (F.No.225/142/2012-ITA.II), dated 01.08.2012, disallowing the expenses incurred on the same.

The Department sought to reopen the assessment for the relevant assessment years by concluding that since the expenses claimed by the petitioner were prohibited by law, they were inadmissible in view of Explanation 1 to Section 37(1) of the Income Tax Act.

As per Explanation 1 to Section 37 claim of any expense is denied, if the same has been incurred for a purpose which is either an offence or is prohibited by law.

After hearing the matter, the bench of Justices Dhiraj Singh Thakur and Kamal Khata opined that;

"In the aforementioned case, two features needs to be highlighted, firstly, that the claim before the Apex Court pertained to the assessment yea 2010-11, to which amendment incorporated in the Regulations 2009 was squarely applicable. The second thing which needs to be highlighted is that in the aforementioned case, the revenue had permitted partial exemption for expenses incurred till 14 December 2009 and held the assessee eligible for the beneft under Section 37(1) but disallowed the expenses incurred thereafter in view of the amendment of 2009. The Apex Court in fact in the judgment Apex Laboratories (P.) Ltd. (supra), has also clearly held that “the CBDT Circular being clarifcatory in nature and was in effect from the date of implementation of Regulation 6.8 of 2002 Regulations, i.e. from 14 December 2009.”"

Perusing the reasons for reopening the assessment, as furnished to the petitioner by the Income Tax Authority, the court said;

“..while the assessing officer had alleged that the assessee had failed to disclose fully and truly all material facts necessary for assessment, the reasons do not at all reflect as to what were those material facts, which had not been disclosed by the Petitioner, which if disclosed would have led the assessing officer to bring to tax such income in the scrutiny assessment.”

The bench further noted;

“The Petitioner was only obliged to disclose the material primary facts and was certainly not obliged to refer to the statutory provisions or the regulations of 2002 at the time of filing the return or during the course of the assessment proceedings.”

Referring to the relevant provisions of the Income Tax Act, the Court noted that as per Section 147, if any income chargeable to tax in the case of an assessee has escaped assessment for any assessment year, the Assessing Officer (AO) may, subject to the provisions of Sections 148 to 153, assess or reassess such income.

Section 148 of the Income Tax Act requires the AO to serve notice on the assessee before making reassessment/ precomputation of Income. As per the proviso to Section 148, no notice under Section 148 shall be issued unless there is information with the AO which suggests that the income chargeable to tax has escaped assessment in the case of the assessee for the relevant assessment year.

While holding that it cannot be said that the petitioner, Abbott India, had not disclosed the relevant material facts during the assessment proceedings, the Court reiterated that the assessment under Section 143(3) can be re-opened only in terms of Section 147 of the Income Tax Act and not otherwise.

The argument that the claim was allowed contrary to the CBDT Circular issued in the year 2012, would not by itself authorize the AO to reassess the income, unless the jurisdictional conditions prescribed under the proviso to Section 148 had been satisfied, the Court said. The bench added that the same, in the present case, were not satisfied at all. “The impugned notice is liable to be quashed and set aside on this ground alone,” the Court ruled.

While reckoning that vide notification dated 10th December, 2009, the Regulations of 2002 were amended to include Clause 6.8, the bench observed;

“It was in the aforementioned backdrop that the Board issued the Circular No.5/2012 dated 1 August 2012 for sensitizing its officers that receipt of gifts, cash, travel facilities and hospitality from the pharmaceutical or allied health sector being prohibited under the regulations of 2002 would be inadmissible under Section 37 being prohibited by law.”

Observing that the Circular No.5/2012 issued by the CBDT, referred to the amended Regulations of 2002, the bench concluded that neither the CBDT Circular nor Regulation 6.8 incorporated in the 2002 Regulations with effect from 10th December 2009, would be applicable to the assessment year 2008-09.

The Court added that it is settled that the law to be applied is the one that is in force in the relevant assessment year, unless otherwise provided expressly or by necessary implication.

The Court, eventually, allowed the petition and set aside the Section 148 notice issued by the revenue department and ruled;

“In our opinion, since the CBDT Circular No.5/12 as also Regulation 6.8 of 2002, were not applicable to the case of the Petitioner for the relevant assessment year 2008-09, there would be no tangible material or basis for the assessing officer to have ‘reason to believe’ that income for the said assessment year 2008-09 had escaped assessment.”

To view the original order, click on the link below:

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News